No significant change was observed in the expression of the receptors in CD19+ B cells of ALL subjects at diagnosis and at the end of induction chemotherapy as compared to healthy subjects (Figure 5f–j). This evidence concerns the gene CD19 and acute lymphoblastic leukemia.